PGIM e-Repository

The Efficiency of Intravitreal Bevacizumab for the Treatment (Primary) of Diabetic Macular Oedema - 03 Month Anatomic and Visual Acuity Response. In a Selected Population in the Northern Territory, Australia. A Hospital Based Study

Files in this item

This item appears in the following Collection(s)

Search DSpace


Browse

My Account